With an annual growth rate of nearly 60 percent, CBD oil has become one of the fastest-growing market categories in the country. U.S.-based ChineseInvestors.com, Inc. (OTCQB: CIIX) is set to capitalize on this meteoric growth.
With an annual growth rate of nearly 60 percent, CBD oil has become one of the fastest-growing market categories in the country. U.S.-based ChineseInvestors.com, Inc. (OTCQB: CIIX) is set to capitalize on this meteoric growth.
ChineseInvestors.com, Inc. (OTCQB: CIIX) is offering a unique opportunity for investors as the company pursues a multi-pronged approach to conquering the rapidly expanding global markets in cannabidiol products and the medical marijuana space in Canada. The company aims to be the world’s leading publicly traded Chinese nutritional company.
Changes in public opinion regarding cannabis have greatly fueled the fire blazing under the red-hot state-legalized marijuana market.
The nutraceutical industry boasts a diversified playing field, and Canada-based Algae Dynamics Corp. (OTCQB: ADYNF) is taking a unique approach to this burgeoning market, focusing on the development of proprietary research and products that combine the health benefits of botanical oils derived from cannabis and algae.
ChineseInvestors.com (OTCQB: CIIX) is a leading financial information website for Chinese-speaking investors in the United States and China.
ChineseInvestors.com, Inc. (OTCQB: CIIX) has been closely monitored for its upside as it competes in the hemp-derived cannabis market. CIIX has launched a cannabidiol (CBD) online store in the free-trade zone of Shanghai and soon it plans to open a brick-and-mortar store in its home market of San Gabriel, California, to market a line of food and nutrition products.
India Globalization Capital, Inc. (NYSE MKT: IGC) has set a long-term goal for itself in the U.S. of becoming a leading provider of cannabis-based pharmaceutical and nutraceutical products.
Combination therapies that use cannabis-based pain reduction methods without the negative side effects of opioids are looking to be a positive growth opportunity among specialty pharmaceuticals, particularly for postoperative and chronic pain relief.
Algae Dynamics Corp. (OTCQB: ADYNF) is uniquely positioned to take advantage of the full legalization of cannabis in Canada by leveraging its expertise and experience with algae oil extraction to expand into the Canadian cannabis oil marketplace.
The strategy by ChineseInvestors.com, Inc. (OTCQB: CIIX) to open the first cannabidiol (CBD) online retail store in China, and to use a wholly-owned subsidiary in the retail and wholesale business to supply CBD health oil products throughout Asia, has attracted the attention of investors who have seen global activity in the cannabis market grow.
Everyone knows there is money to be made in marijuana these days. Americans already spend more on cannabis than ice cream each year, and Canadians are anticipating a combined market that may be larger than the entire domestic alcohol industry by 2020.
ChineseInvestors.com, Inc. (OTCQB: CIIX) is projected to reach revenues of $14.8 million by fiscal year 2020, according to a new research report by Consilium Global Research.
Savvy investors should be keeping a close eye on some key developments that have taken place within the past year relating to Alzheimer’s disease, medical cannabis, and India Globalization Capital (NYSE MKT: IGC)
NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring ChineseInvestors.com, Inc. (OTCQB: CIIX), a client of NNW recognizing unprecedented opportunities in the U.S. cannabis industry and laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.
ChineseInvestors.com, Inc. (OTCQB: CIIX) attended the ‘Invest 2017’ exhibition in Stuttgart, Germany, on April 7-8, 2017, anticipating that the conference would be an opportunity for CIIX to introduce its hemp companies and products to German investors, but CIIX is not alone in seeing the growth opportunities for medical cannabis in that market.